Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald B Kohn

Showing results (11-20 of 272) with videos related to

Pageof 28
Sort By:
Blood Advances|June 23, 2026
Response to "Defining durability in SCD gene therapy"Donald B Kohn, Chattip Prueksapraopong
The Journal of Gene Medicine|June 26, 2003
Letter to the editors of Nature from the American Society of Gene Therapy (ASGT) and the European Society of Gene Therapy (ESGT)Donald B Kohn, Bernd Gänsbacher
The New England Journal of Medicine|January 31, 2009
Gene therapy fulfilling its promiseDonald B Kohn, Fabio Candotti
The Journal of Allergy and Clinical Immunology|August 11, 2020
Overview of the current status of gene therapy for primary immune deficiencies (PIDs)Caroline Y Kuo, Donald B Kohn
The Journal of Allergy and Clinical Immunology|March 9, 2017
New frontiers in the therapy of primary immunodeficiency: From gene addition to gene editingDonald B Kohn, Caroline Y Kuo
Current Allergy and Asthma Reports|April 9, 2016
Gene Therapy for the Treatment of Primary Immune DeficienciesCaroline Y Kuo, Donald B Kohn
Frontiers in Immunology|March 15, 2021
Gene Therapies for Primary Immune DeficienciesLisa A Kohn, Donald B Kohn
Blood|March 9, 2023
β-Thalassemia: all about that base, no cuttingPaul G Ayoub, Donald B Kohn
Hematology/Oncology Clinics of North America|September 13, 2017
Gene TherapyDaniel E Bauer, Donald B Kohn
Science Translational Medicine|August 26, 2011
A tale of two SCIDsKit L Shaw, Donald B Kohn
Pageof 28

Showing results (11-20 of 272) with videos related to

Sort By:
Pageof 28
Blood Advances|June 23, 2026
Response to "Defining durability in SCD gene therapy"Donald B Kohn, Chattip Prueksapraopong
The Journal of Gene Medicine|June 26, 2003
Letter to the editors of Nature from the American Society of Gene Therapy (ASGT) and the European Society of Gene Therapy (ESGT)Donald B Kohn, Bernd Gänsbacher
The New England Journal of Medicine|January 31, 2009
Gene therapy fulfilling its promiseDonald B Kohn, Fabio Candotti
The Journal of Allergy and Clinical Immunology|August 11, 2020
Overview of the current status of gene therapy for primary immune deficiencies (PIDs)Caroline Y Kuo, Donald B Kohn
The Journal of Allergy and Clinical Immunology|March 9, 2017
New frontiers in the therapy of primary immunodeficiency: From gene addition to gene editingDonald B Kohn, Caroline Y Kuo
Current Allergy and Asthma Reports|April 9, 2016
Gene Therapy for the Treatment of Primary Immune DeficienciesCaroline Y Kuo, Donald B Kohn
Frontiers in Immunology|March 15, 2021
Gene Therapies for Primary Immune DeficienciesLisa A Kohn, Donald B Kohn
Blood|March 9, 2023
β-Thalassemia: all about that base, no cuttingPaul G Ayoub, Donald B Kohn
Hematology/Oncology Clinics of North America|September 13, 2017
Gene TherapyDaniel E Bauer, Donald B Kohn
Science Translational Medicine|August 26, 2011
A tale of two SCIDsKit L Shaw, Donald B Kohn
Pageof 28